OM vs. SMLR, ELMD, AXGN, EDAP, FONR, VANI, HYPR, ZYXI, CGEN, and HITI
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Semler Scientific (SMLR), Electromed (ELMD), AxoGen (AXGN), Edap Tms (EDAP), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), Zynex (ZYXI), Compugen (CGEN), and High Tide (HITI). These companies are all part of the "medical" sector.
Semler Scientific (NASDAQ:SMLR) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk, community ranking and earnings.
In the previous week, Outset Medical had 7 more articles in the media than Semler Scientific. MarketBeat recorded 8 mentions for Outset Medical and 1 mentions for Semler Scientific. Semler Scientific's average media sentiment score of 0.02 beat Outset Medical's score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media.
Outset Medical has a consensus target price of $5.42, indicating a potential upside of 50.05%. Given Semler Scientific's higher possible upside, analysts clearly believe Outset Medical is more favorable than Semler Scientific.
Semler Scientific has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Outset Medical has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500.
49.4% of Semler Scientific shares are held by institutional investors. 30.0% of Semler Scientific shares are held by insiders. Comparatively, 3.5% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Outset Medical received 21 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 50.00% of users gave Semler Scientific an outperform vote while only 37.93% of users gave Outset Medical an outperform vote.
Semler Scientific has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
Semler Scientific has a net margin of 32.92% compared to Semler Scientific's net margin of -134.93%. Outset Medical's return on equity of 30.36% beat Semler Scientific's return on equity.
Summary
Semler Scientific beats Outset Medical on 12 of the 19 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Outset Medical Competitors List
Related Companies and Tools
